2018 Shipping and Ordering Supplement - cgikk.com · Insight at a glance. In just seconds, the...

Get the most comprehensive offering of innovative and scientifically developed proficiency testing programs. From routine to esoteric, our programs help you deliver performance you can measure and accuracy you can trust.

• Accuracy-Based Programs

• Anatomic Pathology

• Blood Gas, Critical Care, and Oximetry

• Coagulation

• Continuing Education

• Endocrinology

• Forensic Sciences

• General Chemistry and Therapeutic Drug Monitoring

• Genetics and Molecular Pathology

• Hematology and Clinical Microscopy

• Histocompatibility

• Immunology and Flow Cytometry

• Instrumentation Validation Tools

• Microbiology

• Point-of-Care

• Quality Cross Check

• Quality Management Tools

• Reproductive Medicine

• Toxicology

• Transfusion Medicine, Viral Markers, and Parentage Testing

2018 Shipping and Ordering Surveys and Anatomic Pathology Education Programs

Performance you can measure.

Accuracy you can trust.© 2017 College of American Pathologists. All rights reserved.

25472.0717cap.org

325 Waukegan Road

Northfield, IL 60093-2750

800-323-4040

847-832-7000 (Country code: 001)

FSC logo

Insight at a glance.

In just seconds, the CAP’s Performance Analytics Dashboard provides valuable insights into your laboratory’s performance, letting you proactively focus energy on areas that need immediate attention while filtering out distractions. Updated daily, this complimentary Surveys and CAP accreditation performance monitoring tool reduces the stress of managing today’s laboratory by giving you fast access to a single laboratory’s or an expansive network’s performance.

To view a demo, search Performance Analytics Dashboard at cap.org.

Simplify your calibration verification/linearity efforts.

Calibration and analytical measurement range (AMR) verification procedures are an important element of a laboratory’s quality management plan to verify the continued accuracy of testing systems; and they are requirements of the CAP’s Laboratory Accreditation Program.

Our Calibration Verification/Linearity (CVL) program is a comprehensive solution designed to simplify these procedures and satisfy regulatory requirements.

• Mimic patient testing and ensure confidence in your linearity results with human-based specimens across five to eight levels.

• Receive a customized and easy-to-interpret report package based on rigorous statistical analysis.

• Confidently verify calibration by participating in programs with the largest peer group comparisons.

For program details and ordering information, see the Instrumentation Validation Tools section of the 2018 Surveys catalog, or visit cap.org and click on the SHOP tab.

Expedite results—receive linearity evaluations for most CVL programs within two business days through our LN ExpressSM service.

Surveys Program Shipping

Surveys P

rogram S

hipping

Simplify your workflow with the most comprehensive solution for calibration verification and linearity.• Ensure confidence in your linearity results with 5–8

specimen levels included with each CVL program.

• Receive a customized report with the most rigorous statistical analysis.

• Expedite linearity evaluations through our LN ExpressSM Service.

Sur

veys

Pro

gram

Shi

ppin

g

Look for notification of kit shipment via CAPTRAKerSM. If you do not receive your kit within 7 –10 calendar days following the ship date, or if you receive an incomplete or damaged shipment, please call the Customer Contact Center at 800-323-4040 or 847-832-7000 option 1. R equests for replacements after the 10th calendar day cannot be accepted.

SM

2018 Surveys Program Shipping

2 College of American Pathologists 2018 Surveys & Anatomic Pathology Education Programs


Prog Code

PFGCode

Description Page Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

A2MG A2MG Alpha-2-Macroglobulin 204 A 12 B 30

AAT AAT CAP/ACMG Alpha-1 Antitrypsin Genotyping 239 A 30 B 13

ABF1 ABF1 Automated Body Fluid 146 A 20 B 20



ABL ABL Accuracy-Based Lipids 110 A 19 B 13

ABOSG ABOSG ABO Subgroup Typing 216 A 26 B 30

ABS ABS Accuracy-Based Testosterone, Estradiol 111 A 13 B 17

ABT ABT Antibody Titer, Anti-A and Anti-D 217 A 4 B 29

ABT1 ABT Antibody Titer, Anti-A 217 A 4 B 29

ABT2 ABT Antibody Titer, Anti-D 217 A 4 B 29

ABT3 ABT Antibody Titer, Anti-B 217 A 4 B 29

ABTH ABTH Harmonized Thyroid 112 A 8 B 13

ABU ABU Accuracy-Based Urine 111 A 10 B 18

ABVD ABVD Accuracy-Based Vitamin D 85 A 27 B 9

ACA ACA Antichromatin Antibody 204 A 22 B 6

ACE ACE Angiotensin Converting Enzyme 71 A 3 B 24

ACL ACL Antiphospholipid Antibody 205 A 20 B 5

ADL ADL Aldolase 71 A 21 B 22

AFA AFA Autopsy & Forensic Anthology 270 May be purchased any time during the year

AFL AFL Amniotic Fluid Leakage 146 A 14 B 17

AG AG 1,5-anhydroglucitol 71 A 3 B 22

AHIV AHIV Anti-HIV 1/2 225 A 3 B 13 C 3

AHIVW AHIVW Anti-HIV 1/2, Waived 225 A 13 B 3

AHT S2 Antihistone Antibody 204 A 9 C 17

AL1 AL1 CAP/AACC Whole Blood Alcohol/Volatiles 101 A 26 B 11 C 1

AL2 AL2 CAP/AACC Serum Alcohol/Volatiles 101 A 5 B 4 C 9

AMH AMH Antimüllerian Hormone 84 A 30 B 13

ANA S Antinuclear Antibody 202 A 26 B 20 C 26

APC GIH Autoimmune Gastritis Markers 204 A 30 B 1

APOE APOE CAP/ACMG Apolipoprotein E Genotyping 239 A 5 B 17

APS ACL Antiphosphatidylserine Antibodies 205 A 20 B 5

APT APT Fetal Hemoglobin 148 A 5 B 1

APXBN ACM Apixaban Anticoagulant Monitoring 161 A 16 B 29

AQ AQ Critical Care Blood Gas 92 A 26 B 25 C 22

AQ2 AQ Critical Care Blood Gas w/Chemistry 92 A 26 B 25 C 22

Surveys P

rogram S

hipping


SM

2018 Surveys Program Shipping (Continued)


800-323-4040 | 847-832-7000 Option 1 | cap.org 3

Prog Code

PFGCode


AQ2Q AQQ Quality Cross Check—Blood Gas w/Chemistry

46 A 5 B 13

AQ3 AQI Critical Care Blood Gas, i-STAT 92 A 26 B 25 C 22

AQ3Q AQIQ Quality Cross Check—Blood Gas i-STAT 46 A 5 B 13

AQ4 AQI Critical Care Blood Gas w/Chem, i-STAT 92 A 26 B 25 C 22

AQ4Q AQIQ Quality Cross Check—Bld Gas w/Chemistry i-STAT

46 A 5 B 13

AQQ AQQ Quality Cross Check—Blood Gas 46 A 5 B 13

ARP ARP Antiribosomal P Antibody 205 A 22 B 27

ASA SEM Antisperm Antibody 154 A 23 B 29

ASC ASC Anti-S. cerevisiae Antibody 205 A 14 B 10

ASO S Antistreptolysin O 202 A 26 B 20 C 26

AUP AUP Autopsy Pathology 270 A 26 B 15

AUP1 AUP Autopsy Pathology, Additional Pathologist 270 A 26 B 15

B27 B27 HLA-B27 Typing 231 A 17 B 28

BALL BALL B-ALL Minimal Residual Disease 210 A 15 B 9

BCP KP Blood Cell ID, Photographs 134 A 29 B 7 C 24

BCP2 KP Blood Cell ID, Limited 134 A 29 B 7 C 24

BCR CRS Bile Crystals 147 A 2 B 3

BCS BCS Blood Culture 176 A 25 B 29

BCS1 BCS1 Blood Culture, S. aureus 177 A 2 B 17

BDP BDP Bacterial Detection in Platelets, 2 Challenge

222 A 23 B 22

BDP5 BDP5 Bacterial Detection in Platelets, 5 Challenge

222 A 23 B 16 C 22

BDPV BDPV Bacterial Detection in Platelets, Rapid, 2 Challenge

222 A 24 B 23

BDPV5 BDPV5 Bacterial Detection in Platelets, Rapid, 5 Challenge

222 A 24 B 17 C 23

BFC CRS Body Fluid Crystals 147 A 2 B 3

BGL BGL CAP/ACMG Biochemical Genetics 239 A 13 B 21

BGL1 BGL CAP/ACMG Carnitine, Qual/Quant 239 A 13 B 21

BGS Y Bone and Growth 85 A 30 B 24

BL BL CAP/AACC Blood Lead 102 A 19 B 16 C 29

BMD BMD Bone Marrow Cell Differential 138 A 26 B 27

BMV1 BMV 1,25 Dihydroxy Vitamin D 86 A 9 B 20

BMV2 BMV Bone-Specific Alkaline Phosphatase 86 A 9 B 20

BMV3 BMV Vitamin A 86 A 9 B 20

BMV4 BMV Vitamin E 86 A 9 B 20

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


BMV5 BMV C-Telopeptide 86 A 9 B 20

BMV6 BMV N-Telopeptide 86 A 9 B 20

BNP BNP B-Type Natriuretic Peptides, 2 Challenge 61 A 6 B 30

BNP5 BNP5 B-type Natriuretic Peptides, 5 Challenge 61 A 6 B 12 C 30

BNPQ BNPQ Quality Cross Check—BNP 43 A 30 B 5

BOR BOR B. pertussis/parapertussis, Molecular 177 A 23 B 13

BP BP Blood Parasite 188 A 29 B 21 C 24

BRAF BRAF BRAF 252 A 7 B 13

BRAFV BRAFV BRAF V600E IHC 267 A 21

BRCA BRCA CAP/ACMG BRCA 1/2 Sequencing 240 A 23 B 13

BSTS BST Bact Strain Typing, Staphylococcus 195 A 16 B 20

BU Y Bone and Mineral Metabolism, Urine 85 A 30 B 24

BV BV Bacterial Vaginosis 181 A 3 B 29

C1 C Chemistry—General, Limited 56–58 A 12 B 4 C 1

C3 C Chemistry—General, Comprehensive 56–58 A 12 B 4 C 1

C3X C Chemistry—General, Double Volume 56–58 A 12 B 4 C 1

C4 C Chemistry—Limited 56–58 A 12 B 4 C 1

C7 C Pseudocholinesterase 77 A 12 B 4 C 1

CAMP CAMP Campylobacter 177 A 16 B 20

CBT* CBT Cord Blood Testing 221 A 24 B 8

CCP RDS Cyclic Citrullinated Peptide Antibody 206 A 9 B 20

CD CD Cadmium 102 A 22 B 5 C 4 D 6 E 24 F 26

CDF2 CDF Clostridium difficile, 2 Challenge 178 A 23 C 10

CDF5 CDF Clostridium difficile, 5 Challenge 178 A 23 B 13 C 10

CES CES Celiac Serology 206 A 12 B 17

CESX CES Celiac Serology, Addition Volume 206 A 12 B 17

CFDNA CFDNA Cell Free DNA 252 A 1 B 2

CGB CGL Coagulation—Basic 158 A 29 B 14 C 27

CGDF CGL D-dimer/FDP 158 A 29 C 27

CGE CGE Coagulation—Extended 159 A 26 B 1

CGEX CGE Coagulation—Extended, Additional Material

159 A 26 B 1

CGL CGL Coagulation—Limited 158 A 29 B 14 C 27

CGLQ CGLQ Quality Cross Check—Coagulation 49 A 9 B 9

CGM CGM Coagulation—Limited, Validated Material 167 A 29 B 14 C 27

CGS1 CGS1 Lupus Anticoagulant & Mixing Studies 160–161 A 19 B 4

CGS2 CGS2 Thrombophilia 160–161 A 19 B 4

*Ship date subject to change.

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 5

Prog Code

PFGCode


CGS3 CGS3 von Willebrand Factor 160–161 A 19 B 4

CGS4 CGS4 Heparin 160–161 A 19 B 4

CGS5 CGS5 Heparin-Induced Thrombocytopenia 160–161 A 16 B 22


CGS7 CGS7 ADAMTS14 160–161 A 9 B 13


CH50 CH50 Total Hemolytic Complement 208 A 23 B 5

CHPVD CHPV Human Papillomavirus, Digene 274 A 5 B 6 C 17

CHPVJ CHPV Human Papillomavirus, Mixed Media 274 A 5 B 6 C 17

CHPVK CHPV Human Papillomavirus, SurePath 274 A 5 B 6 C 17

CHPVM CHPV Human Papillomavirus, ThinPrep 274 A 5 B 6 C 17

CMMP CM Urinalysis w/Body Fluid & Urine Sediment Photos

145 A 20 B 10

CMP CM Urinalysis w/Body Fluid & Urine Sediment Photos

144 A 20 B 10

CMP1 CM iChem UA w/Body Fld & Urine Sed Photos 144 A 20 B 10

CMQ CMQ Quality Cross Check—Urinalysis 48 A 14 B 19

CPIP CPIP Clinical Pathology Improvement Program 14 A 15 B 19 C 19 D 16 E 21 F 18 G 16 H 20 I 17 J 15 K 19 L 17

CPIP1 CPIP Clinical Pathology Improvement Program, Additional Participant

14 A 15 B 19 C 19 D 16 E 21 F 18 G 16 H 20 I 17 J 15 K 19 L 17

CRP S C-Reactive Protein 202 A 26 B 20 C 26

CRT CAR Cardiac Markers 62 A 20 B 29 C 9

CRTI CAR Cardiac Markers, Isoenzymes & Troponin I 62 A 20 B 29 C 9

CRYP CRYP Cryptococcal Antigen Detection 185 A 19 B 11 C 1

CS CSM CAP/AACC Immunosuppressive Drugs 59 A 12 B 26

CT CT Activated Clotting Time 162 A 22 B 23

CT1 CT1 Activated Clotting Time 162 A 22 B 23

CT1Q CT1Q Quality Cross Check—ACT 50 A 4 B 10







CTKN CTKN Cytokines 206 A 5 B 20

CTQ CTQ Quality Cross Check—ACT 50 A 4 B 10

CY CY CAP/ACMG Cytogenetics, Online Images 236 A 2 B 5

CYBK CY CAP/ACMG Cytogenetics, Booklet 236 A 2 B 5

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


CYCGH CYCGH CAP/ACMG Constitutional Microarray 238 A 21 B 22

CYCMA CYCMA CAP/ACMG Oncologic Microarray 238 A 12 B 6

CYF CYF CAP/ACMG FISH Constitutional/Hematologic Disorders

236 A 16 B 10

CYH CYH CAP/ACMG FISH, Paraffin-Embedded Tissue

237 A 22 B 9

CYI CYI CAP/ACMG FISH, Urothelial Carcinoma 236 A 26 B 6

CYJ CYP CAP/ACMG FISH, Paraffin-Embedded Tissue

237 A 26 B 6

CYK CYP CAP/ACMG FISH, Paraffin-Embedded Tissue

237 A 26 B 6

CYL CYP CAP/ACMG FISH, Paraffin-Embedded Tissue

237 A 26 B 6

CYS CYS Cystatin C 74 A 16 B 10

CZ C Chemistry/Therapeutic Drug Monitoring 56–58 A 12 B 4 C 1

CZ2X C Chemistry/TDM, Triple Volume 56–58 A 12 B 4 C 1

CZQ CZQ Quality Cross Check—Chemistry/Therapeutic Drug Monitoring

43 A 16 B 10

CZVM CZVM Chemistry/TDM, Validated Material 67 A 12 B 4 C 1

CZX C Chemistry/TDM, Double Volume 56–58 A 12 B 4 C 1

D D Bacteriology 170 A 5 B 11 C 9

D1 D1 Throat Culture 172 A 2 B 13 C 3

D2 D2 Urine Culture 172 A 2 B 13 C 3

D3 D3 N. gonorrhoeae Culture 172 A 2 B 13 C 3

D4 D4 Bacteriology—Limited 173 A 3 B 13 C 3

D5 D5 Gram Stain 174 A 9 B 20 C 10

D6 D6 Rapid Group Strep A Antigen Detection 175 A 9 B 13 C 10

D7 D7 Throat/Urine Culture 172 A 3 B 13 C 3

D8 D8 Group B Strep Detection 176 A 30 B 16 C 3

D9 D9 Rapid Strep Antigen Detection, Waived 175 A 2 B 6

DADR1 DADR HLA Disease Association-Drug Risk 233 A 17 B 28

DADR2 DADR HLA Disease Association-Drug Risk 233 A 17 B 28

DAI DAI Urine Drug Adulterant/Integrity 98 A 13 B 14

DAT DAT Direct Antiglobulin Testing 218 A 26 B 15

DBGN ACM Dabigatran Anticoagulant Monitoring 161 A 16 B 29

DEX DEX Expanded Bacteriology 171 A 12 B 4 C 15

DFC DFC Drug-Facilitated Crime 107 A 5 B 4

DML DML Class I & II HLA Molecular Typing 231 A 20 B 5 C 2

DMPM DMPM Drug Monitoring for Pain Management 106 A 13 B 14

DPATH DPATH Digital Slide Program—Dermatopathology 259 A 18 B 17

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 7

Prog Code

PFGCode


DPATH1 DPATH Digital Slide Program—Dermpath, Additional Pathologist

259 A 18 B 17

DSC CM Dipstick Confirmatory Testing 147 A 20 B 10

DY Y Ligand Assay—Testosterone, SHBG 84 A 30 B 24

E E Mycobacteriology 183 A 5 B 4

E1 E1 Mycobacteriology—Limited 183 A 26 B 27

EGFR EGFR EGFR 252 A 5 B 4

EHE1 EHE Expanded Virtual Peripheral Blood Smear 142 A 23 B 22

ELU ELU Eluate 218 A 19 B 2

EMB EMB Embryology 155 A 11 B 29

EPO Y Erythropoietin 86 A 30 B 24

ESR ESR Erythrocyte Sedimentation Rate 134 A 21 B 10

ESR1 ESR1 Erythrocyte Sedimentation Rate 134 A 21 B 10



ETB ETB Ethanol Biomarkers 102 A 5 B 4

ETME1 ETME Expanded Transfusion Medicine Exercises 223 A 12 B 1

EV EV Everolimus 59 A 24 B 18

EXM J Electronic Crossmatch 215 A 12 C 10

EXM2 JAT Electronic Crossmatch, Automated 216 A 19 C 1

F F Mycology and Aerobic Actinomycetes 184 A 29 B 7 C 27

F1 F1 Yeast 184 A 20 B 29 C 17

F3 F3 Candida Culture 185 A 5 B 9 C 13

FCFS FCFS Fecal Fat 75 A 5 B 17

FCN FCN Antifilamentous Actin IgG Antibody 204 A 30 B 13

FF FF Fetal Fibronectin 86 A 2 B 3

FGAL FGAL Galactomannan 185 A 16 B 20

FH1 FH1 Hematology Automated Differential Series 135 A 29 B 7 C 24

FH1P FH1 Hematology Automated Differential Blood Cell ID

135 A 29 B 7 C 24



135 A 29 B 7 C 24



135 A 29 B 7 C 24

FH3Q FH3Q Quality Cross Check—Hematology 47 A 26 B 23



135 A 29 B 7 C 24

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode





135 A 29 B 7 C 24




135 A 29 B 7 C 24




135 A 29 B 7 C 24



135 A 29 B 7 C 24

FH15 FH15 Centrifugal Hematology 135 A 26 B 23 C 26

FID FID Forensic Identity, Nuclear DNA Analysis 280 A 6 B 17

FL FL Flow Cytometry Combo (FL1/FL2) 209 A 12 B 18 C 15

FL1 FL Flow Cytometry, Lymphocyte Phenotype 209 A 12 B 18 C 15

FL2 FL Flow Cytometry, DNA Analysis 209 A 12 B 18 C 15

FL3 FL3 Flow Immunophen Leukemia/Lymphoma 209 A 6 B 18

FL4 FL4 Flow Cytometry, CD34+ 209 A 16 B 22

FL5 FL5 Flow Cytometry, Interpretation Only 210 A 12 B 20

FLAC FLAC Fecal Lactoferrin 178 A 23 B 27

FLD FLD Body Fluid Chemistry 72 A 12 B 6

FLD2 FLD2 Body Fluid Chemistry 2 73 A 12 B 6

FLDQ FLDQ Quality Cross Check—Body Fluid Chemistry

44 A 16 B 1

FNA FNA Digital Slide Program in Fine-Needle Aspiration

277 A 23 B 22

FNA1 FNA Digital Slide Program in Fine-Needle Aspiration, Individual

277 A 23 B 22

FNAG FNAG Fine-Needle Aspiration Glass Slides, Laboratory

278 A 14 B 17

FNAG1 FNAG Fine-Needle Aspiration Glass Slides, Individual

278 A 14 B 17

FNPX ACM Fondaparinux Anticoagulant Monitoring 161 A 16 B 29

FOL K RBC Folate 88 A 9 B 23 C 13

FP FP Second Trimester Maternal Screening 87 A 19 B 6 C 13

FP1B FP 1st Trimester Maternal Screen, Free Beta 87 A 19 B 6 C 13

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 9

Prog Code

PFGCode


FP1T FP 1st Trimester Maternal Screen, Total Beta 87 A 19 B 6 C 13

FPX FP Second Trimester Maternal Screen, Additional Material

87 A 19 B 6 C 13

FR FR Forensic Pathology 281 A 21 B 26

FR1 FR Forensic Pathology, Additional Pathologist 281 A 21 B 26

FSER FSER Fungal Serology 185 A 23 B 27

FSM FSM Fungal Smear 186 A 26 B 9

FT FT Fructosamine 75 A 7 B 13

FTC FTC Forensic Toxicology, Criminalistics 104 A 12 B 17

G G Syphilis Serology 208 A 16 B 30 C 17

G6PDS G6PDS Glucose-6-Phosphate Dehydrogenase 75 A 26 B 15

GH2 GH2 Hemoglobin A1c, 3 Challenge 63 A 24 B 13

GH5 GH5 Hemoglobin A1c, 5 Challenge 63 A 24 B 24 C 13

GH5I GH5I Hemoglobin A1c, International 63 A 5 B 18 C 22

GHER2 GHER2 Gastric HER2 269 A 26 B 20

GHQ GHQ Quality Cross Check—Hemoglobin A1c 44 A 11 B 10

GIP GIP Gastrointestinal Panel 199 A 2 B 1

GLI GLI Glioma 253 A 19 B 20

GNBC GPBC Gram-Negative Blood Culture Panel 199 A 2 B 1

GOCB CM Gastric Occult Blood 148 A 20 B 10

GPBC GPBC Gram-Positive Blood Culture Panel 199 A 2 B 1

GSA GSA Glycated Serum Albumin 64 A 7 B 13

H GIH Antimitochondrial M2 Antibody 204 A 30 B 1

HBF HBF Fetal Red Cell Detection 218 A 30 B 5

HBVL HVL Hepatitis B Viral Load, 3 Challenge 193 A 6 C 2

HBVL5 HVL Hepatitis B Viral Load, 5 Challenge 193 A 6 B 29 C 2

HC1 HC1 Chlamydia Antigen Detection (DFA) 178 A 12 B 16 C 29

HC2 HC2 Herpes Simplex, Antigen Detection (DFA) 192 A 12 B 16 C 29

HC3 HC3 C. trachomatis Antigen Detection (EIA) 178 A 29 B 30 C 10

HC4 HC4 Herpes Simplex Virus, Culture 192 A 26 B 11 C 24

HC6 HC6 C. trachomatis/N. gonorrhoeae by Nucleic Acid Amplification (NAA)

194 A 22 B 21 C 24

HC6X HC6 C. trachomatis/N. gonorrhoeae by Nucleic Acid Amplification (NAA), Additional Material

194 A 22 B 21 C 24

HC7 HC7 C. trachomatis/N. gonorrhoeae with DNA 194 A 5 B 23 C 15

HCC HCC Waived Combination 66 A 12 B 24

HCC2 HCC2 Waived Combination 66 A 5 B 18 C 17 D 15

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


HCG S HCG, Serum 202 A 26 B 20 C 26

HCV2 HVL Hepatitis C Viral Load 193 A 6 B 29 C 2

HE HE Hematology—Basic 134 A 29 B 7 C 24

HEP HE Hematology—Basic with Blood Cell ID 134 A 29 B 7 C 24

HER2* HER2 HER2 Immunohistochemistry 269 A 20 B 6

HFC HFC Hemocytometer Fluid Count 148 A 6 B 26

HFCI HFCI Hemocytometer Fluid Count, International 149 A 17 B 10

HG HG Hemoglobinopathy 139 A 12 B 13

HGM HGM CAP/ACMG Hemoglobinopathies Genotyping

240 A 5 B 13

HIVG HIV HIV Genotyping 193 A 6 B 29 C 2

HMS CR Homocysteine 64 A 2 B 5

HPATH HPATH Hematopathology Online Education 143 A 21 B 19

HPATH1 HPATH Hematopathology Online Education, Each Additional Participant

143 A 21 B 19

HPS HPS H. pylori Antigen, Stool 178 A 2 B 17

HPV HPV Human Papillomavirus 195 A 25 B 22

HQBX1 HQBX1 CAP/NSH Gastrointestinal Biopsy 266 A 5 B 23

HQBX2 HQBX2 CAP/NSH Dermatologic Biopsy 266 A 5 B 23

HQBX3 HQBX3 CAP/NSH Urogenital Tract Biopsy 266 A 5 B 23

HQBX4 HQBX4 CAP/NSH Gynecologic Biopsy 266 A 5 B 23

HQIHC HQIHC CAP/NSH HistoQIP Immunohistochemistry 264 A 5 B 23

HQIP HQIP CAP/NSH HISTOQIP 263 A 5 B 23

HQIPBX HQIPBX CAP/NSH HISTOQIP Biopsy Series 265 A 5 B 23

HQMMR HQIHC CAP/NSH HistoQIP Mismatch Repair IHC 264 A 5 B 23

HQNSC HQIHC HQIP Non-small Cell Lung Carcinoma IHC 265 A 5 B 23

HSCRP CR High Sensitivity C-Reactive Protein 64 A 2 B 5

HUEP HUEP Human Epididymis Protein 5 89 A 22 B 30

HV2 HIV HIV Viral Load 193 A 6 B 29 C 2

I I Instrumentation 129 A 3 B 30 C 3

ID1 ID1 Nucleic Acid Amplification, Viruses 196 A 16 B 22

ID1T ID1 Nucleic Acid Amplification, JC & BK 196 A 16 B 22

ID2 ID2 Nucleic Acid Amplification, Respiratory 197 A 16 B 22

ID3 ID3 Influenza A, Influenza B, and RSV by NAA 197 A 12 B 16 C 3

IDME IDME Meningitis/Encephalitis Panel 198 A 2 B 10

IDN IDO NAA, Organisms Without MTB 196 A 16 B 22

IDO IDO Nucleic Acid Amplification, Organisms 196 A 16 B 22

IDR IDR Infectious Disease, Respiratory Panel 198 A 12 B 16 C 3


Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 11

Prog Code

PFGCode


IFS IFS Interfering Substances 130 A 8

IG S Immunology—General 202 A 26 B 20 C 26

IGHV IGHV IGHV Mutation Analysis 250 A 3 B 6

IGX S Immunology—General, Double Volume 202 A 26 B 20 C 26

IL S Immunology—Comprehensive 202 A 26 B 20 C 26

IM S Infectious Mononucleosis 202 A 26 B 20 C 26

IMD1 IMD CAP/ACMG Mitochondrial DNA Deletion Syndrome

242 A 2 B 1

IMD2 IMD CAP/ACMG MCAD 242 A 2 B 1

IMD3 IMD CAP/ACMG Mitochondrial Cytopathies 242 A 2 B 1

IMW IMW Infectious Mononucleosis, Waived 203 A 3 B 13

IND IND India Ink 186 A 14 B 10

ING Y Insulin, Gastrin, C-Peptide, and PTH 86 A 30 B 24

ISH ISH In Situ Hybridization 250 A 22 B 9

ISH2 ISH In Situ Hybridization, HER2 (ERBB2) 250 A 22 B 9

J J Transfusion Medicine—Comprehensive 214 A 12 B 11 C 10

J1 J1 Transfusion Medicine—Limited 214 A 12 B 11 C 10

JAT JAT Transfusion Medicine—Automated 215 A 19 B 25 C 1

JATE1 JAT Transfusion Medicine—Automated Educational Challenge

215 A 19 B 25 C 1

JE1 J Transfusion Medicine—Educational Challenge

214 A 12 B 11 C 10

K K Ligand—General 82 A 9 B 23 C 13

K2 K2 Ligand—Limited 82 A 9 B 13

KET KET Ketones 64 A 7 B 13

KIT KIT KIT/PDGFRA 252 A 16 B 29

KK K Ligand—General, Double Volume 82 A 9 B 23 C 13

KRAS KRAS KRAS 252 A 21 B 19

KSA KSA Kidney Stone Assessment 69 A 29 B 26

KVM KVM Ligand Assay—General, Validated Material 90 A 9 B 23 C 13

LBAS BAS Legionella Antigen Detection 176 A 5 B 13

LBC LBC Lamellar Body Count 149 A 23 B 29

LCW LCW Chemistry—Limited, Waived 64 A 5 B 15

LKM GIH Liver-Kidney Microsomal Antibody 207 A 30 B 1

LN2 LN2 Chemistry/Lipid/Enzyme Calibration Verification/Linearity

118 A 18 B 10

LN2BV LN2BV Chem CVL Beck (Except AU), Vitros Calibration Verification/Linearity

118 A 18 B 10

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


LN3 LN3 Therapeutic Drug Monitoring Calibration Verification/Linearity

119 A 21 B 19

LN5 LN5 Ligand Assay Calibration Verification/Linearity

119–120 A 4 B 26

LN5S LN5S Ligand Assay, Siemens Calibration Verification/Linearity

119–120 A 4 B 26

LN6 LN6 Urine Chemistry Calibration Verification/Linearity

120 A 21 B 19

LN7 LN7 Immunology Calibration Verification/Linearity

121 A 23 B 15

LN8 LN8 Reproductive Endocrinology Calibration Verification/Linearity

121 A 9 B 1

LN9 LN9 Hematology Calibration Verification/Linearity

121 A 9 B 1

LN11 LN11 Serum Ethanol Calibration Verification/Linearity

122 A 16 B 10

LN12 LN12 C-Reactive Protein Calibration Verification/Linearity

122 A 16 B 10

LN12E LN12E C-Reactive Protein, Extended Calibration Verification/Linearity

122 A 16 B 10

LN13 LN13 Blood Gas Calibration Verification/Linearity 122–123 A 16 B 10

LN13C LN13 Blood Gas/Critical Care Calibration Verification/Linearity

122–123 A 16 B 10

LN15 LN15 Hemoglobin A1c Accuracy Calibration Verification/Linearity

123 A 13 B 18

LN16 LN16 Homocysteine Calibration Verification/Linearity

123 A 12 B 17

LN17 LN17 Whole Blood Glucose Calibration Verification/Linearity

123 A 26 B 27

LN18 LN18 Reticulocyte Calibration Verification/Linearity

124 A 26 B 1

LN19 LN19 Reticulocyte Calibration Verification/Linearity

124 A 26 B 1

LN20 LN20 Urine Albumin Calibration Verification/Linearity

124 A 16 B 15

LN21 LN21 High-Sensitivity CRP Calibration Verification/Linearity

124 A 16 B 15

LN22 LN22 Flow Cytometry Calibration Verification/Linearity

124 A 2 B 9

LN23 LN23 Prostate-Specific Antigen Calibration Verification/Linearity

125 A 29 B 26

LN24 LN24 Creatinine Accuracy Calibration Verification/Linearity

125 A 22 B 20

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 13

Prog Code

PFGCode


LN25 LN25 Troponin I Calibration Verification/Linearity 125 A 27 B 25

LN27 LN27 Troponin T Calibration Verification/Linearity

125 A 26 B 24

LN30 LN30 B-Type Natriuretic Peptide Calibration Verification/Linearity

125 A 19 B 18

LN31 LN31 Immunosuppressive Drug Calibration Verification/Linearity

126 A 24 B 30

LN32 LN32 Ammonia Calibration Verification/Linearity 126 A 29 B 19

LN33 LN33 Serum Myoglobin Calibration Verification/Linearity

126 A 21 B 19

LN34 LN34 Tumor Markers Calibration Verification/Linearity

126 A 23 B 22

LN35 LN35 Thrombophilia Calibration Verification/Linearity

127 A 6 B 28

LN36 LN36 Heparin Calibration Verification/Linearity 127 A 3 B 2

LN37 LN37 von Willebrand Factor Antigen Calibration Verification/Linearity

127 A 1 B 30

LN38 LN38 CMV Viral Load Calibration Verification/Linearity

127 A 6 B 4

LN39 LN39 HIV Viral Load Calibration Verification/Linearity

127 A 7 B 5

LN40 LN40 Vitamin D Calibration Verification/Linearity 127 A 7 B 5

LN41 LN41 Procalcitonin Calibration Verification/Linearity

128 A 8 B 13

LN42 LN42 D-Dimer Calibration Verification/Linearity 128 A 16 B 15

LN43 LN43 Lamellar Body Count Calibration Verification/Linearity

128 A 30 B 5

LN44 LN44 Fibrinogen Calibration Verification/Linearity

128 A 15 B 13

LN45 LN45 HCV Viral Load Calibration Verification/Linearity

127 A 1 B 6

LPE ELP Lipoprotein Electrophoresis 76 A 30 B 13

LPX LPX Laboratory Preparedness Exercise 180 A 9 B 10

M M Cerebrospinal Fluid Chemistry 74 A 9 B 4

MBT MBT Micro Bench Tools Competency 171 A 2 B 1

MC1 MC1 Microbiology—Combination w/GC 173 A 3 B 13 C 10

MC2 MC2 Microbiology—Combination 173 A 3 B 13 C 10

MC3 MC3 Urine Colony Count 174 A 26 B 6 C 10

MC4 MC4 Urine Colony Count Combination 174 A 3 B 6 C 10

MC5 MC5 Throat & Urine Cult/Rapid Strep A AG Det 174 A 3 B 13 C 10

ME ME Monitoring Engraftment 232 A 27 B 1 C 14

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


MGL1 MGL CAP/ACMG Molecular Genetics 241 A 26 B 15




MGL5 MGL CAP/ACMG Cystic Fibrosis 241 A 26 B 15

MHO MHO MHO, Lymphoma 254 A 24 B 23

MHO1 MHO MHO1, Lymphoma, Double Volume 254 A 24 B 23

MHO2 MHO MHO2, Leukemia Only 254 A 24 B 23

MHO3 MHO MHO3, Leukemia Only, Double Volume 254 A 24 B 23

MHO5 MHO DNA Extraction & Amplification FFPE 251, 254 A 24 B 23

MK MK Immunohistochemistry 267 A 20 B 20

MMR MMR DNA Mismatch Repair 267 A 18 B 22

MPA CSM Mycophenolic Acid 59 A 12 B 26

MRD MRD Minimal Residual Disease, BCR/ABL1 p210 254 A 24 B 9

MRD1 MRD Minimal Residual Disease, BCR/ABL1 p190 254 A 24 B 9

MRD2 MRD Minimal Residual Disease, PML/RARA 254 A 24 B 9

MRS MRS Methicillin Resistant S. aureus, 2 Challenge 179 A 5 B 9

MRS2M MRS2M MRSA Screen, Molecular, 2 Challenge 179 A 2 B 5

MRS5 MRS5 Methicillin Resistant S. aureus, 5 Challenge 179 A 5 B 4 C 9

MRS5M MRS5M MRSA Screen, Molecular, 5 Challenge 179 A 2 B 16 C 5

MSI MSI Microsatellite Instability 250 A 18 B 22

MTBR MTBR Molecular MTB ID & Resistance Detection 183 A 11 B 13

MTP MTP Multigene Tumor Panel 253 A 30 B 29

MVM MVM Cerebrospinal Fluid, Validated Material 80 A 9 B 4

MX1B MX1 HLA XMatch, Antibody Screen & ID (Class I) 230 A 30 B 22 C 23

MX1C MX1 HLA XMatch, Antibody Screen & ID (Class I) 230 A 30 B 22 C 23

MX1E MX1 HLA Antibody Screen & ID (Class I) 230 A 30 B 22 C 23

MX2B MX2 HLA XMatch, Antibody Screen & ID (Class II)

230 A 3 B 31 C 27

MX2C MX2 HLA XMatch, Antibody Screen & ID (Class II)

230 A 3 B 31 C 27

MX2E MX2 HLA Antibody Screen & ID (Class II)

230 A 3 B 31 C 27

MXBMX1

MX1B/MX2B Combination, Class I & II 231A 30 B 22 C 23

MX2 A 3 B 31 C 27

MXC MX1 MX1C/MX2C Combination, Class I & II 231 A 30 B 22 C 23

MXC MX2 MX1C/MX2C Combination, Class I & II 231 A 3 B 31 C 27

MYG MYG Myoglobin, Urine 69 A 26 B 23

N N Urine Chemistry—Special 69 A 26 B 16

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 15

Prog Code

PFGCode


NAT NAT Nucleic Acid Testing 226 A 19 B 16 C 15

NB NB Neonatal Bilirubin, 5 Challenge 65 A 5 B 18 C 22

NB2 NB2 Neonatal Bilirubin, 2 Challenge 65 A 5 B 22

NEO NEO Neoplastic Cellularity 251 A 12 B 24

NGC NGC Interlab Comp Non-GYN Cytology, Laboratory

276 A 1/22 - 2/12

B 4/16 - 5/7

C

7/23 - 8/13

D

10/15 - 11/5

NGC1 NGC Interlab Comp Non-GYN Cytology, Individual

276 A 1/22 - 2/12

B 4/16 - 5/7

C 7/23 - 8/13

D 10/15 - 11/5

NGS NGS Next-Generation Sequencing Germline 246 A 5 B 17

NGSB1 NGSB NGS Bioinformatics for Illumina 247 A 4 B 26

NGSB2 NGSB2 NGS Bioinformatics for Ion Torrent 247 A 4 B 26

NGSBV NGSBV NGS Bioinformatics Somatic Validated Material

249 A 11 B 26

NGSE NGSE NGS Undiagnosed Disorders-Exome 248 A 5 B 17

NGSHM NGSHM NGS Hematologic Malignancies 246 A 20 B 28

NGSST NGSST NGS Solid Tumor 246 A 27 B 2

NIPT NIPT Non-Invasive Prenatal Testing 87 A 30 B 5

NP NP Neuropathology Program 271 A 19 B 17

NP1 NP Neuropathology Program, Additional Pathologist

271 A 19 B 17

NTA NTA Nicotine and Tobacco Alkaloids 102 A 1 B 6

NX N Urine Chemistry—Special, Double Volume 69 A 26 B 16

OCB CM Occult Blood 149 A 20 B 10

OCBQ OCBQ Quality Cross Check—Occult Blood 48 A 16 B 22

OFD OFD Oral Fluid for Drugs of Abuse 100 A 5 B 29 C 4 D 3

OLI M CSF Chemistry w/Oligoclonal Bands 74 A 9 B 4

P P Parasitology 187 A 5 B 25 C 5

P3 P Parasite, Fecal Suspension, Immunoassay 187 A 5 B 25 C 5

P4 P Parasite, Fecal Suspension, PVA, Immunoassay

187 A 5 B 25 C 5

P5 P Parasitolgy, Giardia/Crypto Immunoassay 187 A 5 B 25 C 5

PAP Prog.

PAP PAP PT and Education Programs 272 For PAP shipping and pricing information, refer to page 22.

PARF PARF Parentage/Relationship Test—Filter Paper 227 A 20 B 25 C 24

PCARM PCARM Plasma Cardiac Markers 65 A 5 B 11 C 15

PCARMX PCARM Plasma Cardiac Markers, Double Volume 65 A 5 B 11 C 15

PCNEO PCNEO Flow Cytometry - Plasma Cell Neoplasms 211 A 1 B 16

PCP1 PCP1 Pneumocystis, Calcofluor White Stain 186 A 4 B 10

PCP2 PCP2 Pneumocystis, DFA Stain 186 A 4 B 10

PCP4 PCP4 Pneumocystis, GMS Stain 186 A 4 B 10

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


PCSP PCSP Cancer Staging Improvement Program 262 A 4

PCSP1 PCSP Cancer Staging Improvement Program, Additional Pathologist

262 A 4

PCT PCT Procalcitonin 77 A 5 B 27

PDL1 PDL1 PD-L1 267 A 13

PEX PEX Expanded Parasitology 189 A 16 B 15

PF PF Platelet Aggregation 164 A 12 B 15

PF1 PF1 Platelet Function 164 A 12 B 15

PGX PGX Pharmacogenetics 243 A 23 B 17

PGX1 PGX IL28B Genotyping 243 A 23 B 17

PGX2 PGX HLA Drug Hypersensitivity 243 A 23 B 17

PGX3 PGX DPYD, TPMT, UGT1A1 Genotyping 243 A 23 B 17

PHG PHG Plasma Hemoglobin 76 A 2 B 17

PIA PIA Drug-Specific Platelet Aggregation 165 A 16 B 22

PIAX PIA Drug-Specific Platelet Aggregation, Double Volume

165 A 16 B 22

PIP PIP Performance Improvement Program in Surgical Pathology

256 A 19 B 11 C 17 D 10

PIP1 PIP Performance Improvement Program in Surgical Pathology, Additional Pathologist

256 A 19 B 11 C 17 D 10

PIPW PIPW Online Performance Improvement Program, Surgical Pathology

257 A 19 B 11 C 17 D 10

PIPW1 PIPW Online Performance Improvement Program, Surgical Pathology, Additional Pathologist

257 A 19 B 11 C 17 D 10

PLA PLA Lipoprotein-Associated Phospholipase A2 75 A 3 B 1

PLTM PLTM Platelet Mapping 167 A 12 B 15

PM1 PM1 CD117, IHC Tissue Microarray 268 A 3

PM2 PM2 ER/PGR, IHC Tissue Microarray 269 A 29 B 5

PM3 PM3 CD20, IHC Tissue Microarray 268 A 4

PM5 PM5 IHC Tissue Microarray Series 268 A 23

PM6 PM6 Anaplastic Lymphoma Kinase IHC TMA 268 A 10

PNA1 PNA PNA FISH for Staphylococcus 177 A 23 B 22

PNA2 PNA PNA FISH for Yeast 177 A 23 B 22

PNH* PNH Flow PNH Immunophenotyping 211 A 1 B 30

POC1 POC1 POC hCG Competency 52 May be purchased any time during the year

POC2 POC2 POC Glucose Competency 52 May be purchased any time during the year

POC3 POC3 POC Urine Dipstick Competency 52 May be purchased any time during the year

POC4 POC4 POC Strep Screen Competency 52 May be purchased any time during the year

POC6 POC6 POC PT/INR, CoaguChek XS+ Competency 52 May be purchased any time during the year

POC7 POC7 POC Waived Glucose & Hemoglobin Comp 52 May be purchased any time during the year


Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 17

Prog Code

PFGCode


POC8 POC8 POC Influenza AB Antigen Detect Competency

52 May be purchased any time during the year

POC9 POC9 POC Fecal Occult Blood Competency 52 May be purchased any time during the year

POC10 POC10 POC Blood Gases Competency 53 May be purchased any time during the year

POC11 POC11 POC Blood Gases, i-STAT Competency 53 May be purchased any time during the year

POC12 POC12 POC Plasma Cardiac Markers Competency 53 May be purchased any time during the year

POC14 POC14 POC Medtronic ACT/ACT, i-STAT Competency


POC15 POC15 POC Hemochron Jr IL GEM ACT-LR Competency


POC16 POC16 POC Hemochron Jr Signature IL GEM Competency


PRO QPR All Four QP Studies N/A B 19 C 11 D 4 A 4

PS PS Platelet Serology 219 A 19 B 22

PTHQ PTHQ Quality Cross Check—Parathyroid Hormone

45 A 21 B 13

PV SEM Semen Analysis 154 A 23 B 29

QF QF M. tuberculosis Infection Detection 207 A 21 B 22

QM1 QM Monitoring of Troponin Metrics for MI 39 B 5 C 4 D 4 A 4

QP181 QPR Physician Satisfaction with Clinical Laboratory

25 A 4

QP182 QPR Laboratory Staff Turnover 26 B 19

QP183 QPR Technical Competency Assessment of Body Fluid

27 C 11

QP184 QPR Laboratory Result Turnaround Time for Emergency Room Specimens

28 D 4

QT1 QTR Patient Identification Accuracy 31 B 5 C 4 D 4 A 4

QT2 QTR Blood Culture Contamination 31 B 5 C 4 D 4 A 4

QT3 QTR Laboratory Specimen Acceptability 32 B 5 C 4 D 4 A 4

QT4 QTR Blood Product Wastage 32 B 5 C 4 D 4 A 4

QT5 QTR Gynecologic Cytology Outcomes 37 B 5 C 4 D 4 A 4

QT7 QTR Outpatient Satisfaction with Phlebotomy Service

33 B 5 C 4 D 4 A 4

QT8 QTR Stat Test Turnaround Time Outliers 33 B 5 C 4 D 4 A 4

QT10 QTR Critical Values Reporting 34 B 5 C 4 D 4 A 4

QT15 QTR Turnaround Time of Troponin 35 B 5 C 4 D 4 A 4

QT16 QTR Corrected Results 35 B 5 C 4 D 4 A 4

QT17 QTR Outpatient Order Entry Errors 36 B 5 C 4 D 4 A 4

QTC QTR All Q-TRACK Clinical Path Studies N/A B 5 C 4 D 4 A 4

QTP QTR All Q-TRACK Clin/Anat Path Studies N/A B 5 C 4 D 4 A 4

R R Trace Metals 78 A 3 B 30

RAG RAG Red Blood Cell Antigen Genotyping 216 A 26 B 22

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


RAP Y Renin and Aldosterone 89 A 30 B 24

RBCAT RBCAT Red Blood Cell Antigen Typing 217 A 26 B 5

RDS RDS Rheumatic Disease Special Serologies 207 A 9 B 20

RETT RETT CAP/ACMG Rett Syndrome (MECP2) 243 A 5 B 17

RF S Rheumatoid Factor 202 A 26 B 20 C 26

RFAV1 RFAV Rare Flow Antigen Validation, CD1A 212 A 24 B 23

RFAV2 RFAV2 Rare Flow Antigen Validation, CD103 212 A 24 B 23

RFX S Rheumatoid Factor, Double Volume 202 A 26 B 20 C 26

RHCVW RHCVW Anti-HCV, Rapid Methods, Waived 225 A 30 B 5

RMAL RMAL Rapid Malaria 188 A 29 B 19

RNA RNA RNA Sequencing 252 A 27 B 21

ROM1 ROM1 Rupture of Fetal Membranes 150 A 14 B 17

RT RT Reticulocyte 139 A 29 B 17

RT2 RT2 Reticulocyte 139 A 29 B 17

RT2Q RT2Q Quality Cross Check—Reticulocyte 47 A 18 B 17





RTQ RTQ Quality Cross Check—Reticulocyte 47 A 18 B 17

RUB S Rubella 202 A 26 B 20 C 26

RUBX S Rubella, Double Volume 202 A 26 B 20 C 26

RUR RUR Rapid Urease 180 A 30 B 13

RVBN ACM Rivaroxaban Anticoagulant Monitoring 161 A 16 B 29

RWBC RWBC Rapid Total Whole Blood Cell Count 141 A 16 B 20 C 10

S2 S2 Immunology—Special 203 A 9 B 13 C 17

S4 S2 Immunology—Special, Limited 203 A 9 B 13 C 17

S5 S2 Immunology—Special, H. pylori IgG 203 A 9 B 13

SALC SALC Salivary Cortisol 77 A 17 B 4

SARC SARC Sarcoma Translocation 251 A 15 B 27

SBAS BAS S. pneumoniae Antigen Detection 176 A 5 B 13

SC SEM Sperm Count 154 A 23 B 29

SC1 SEM Automated Sperm Count 154 A 23 B 29

SCDD SCDD Synthetic Cannabinoid/Designer Drugs 105 A 2 B 24

SCM1 SCM Urine Hemosiderin, Prussian Blue 150 A 19 B 13

SCM2 SCM Urine Eosinophils, Wright Stain 150 A 19 B 13

SCO SCO Serum Carryover 131 A 14

SCP SCP Stem Cell Processing 221 A 10 B 16

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 19

Prog Code

PFGCode


SCS SCS Sickle Cell Screening 140 A 5 B 13

SDS SDS Serum Drug Screening 101 A 26 B 5

SE SE Diagnostic Allergy 207 A 3 B 13 C 26

SEC SEC CAP/ACMG DNA Sequencing Interpretation 242 A 23 B 10

SEC1 SEC1 CAP/ACMG DNA Sequencing 242 A 30 B 29

SFLC SFLC Serum Free Light Chains 208 A 16 B 29

SM SEM Sperm Morphology 154 A 23 B 29

SM1CD SPCD Sperm Morphology on CD 154 A 23 B 29

SM2CD SPCD Sperm Viability on CD 154 A 23 B 29

SMCD SPCD Sperm Count and Motility on CD 154 A 23 B 29

SO SO Blood Oximetry 94 A 23 B 16 C 29

SOQ SOQ Quality Cross Check—Blood Oximetry 46 A 26 B 4

SP SP Stool Pathogens 180 A 21 B 5

SP1 SP Norovirus 180 A 21 B 5

SPE ELP Protein Electrophoresis 76 A 30 B 13

SPN SP Stool Pathogen, without Shigatoxin 180 A 21 B 5

ST ST Shiga Toxin 181 A 20 B 13

STFR STFR Soluble Transferrin Receptor 80 A 23 B 27

SV SEM Sperm Viability 154 A 23 B 29

SW1 SW Sweat Analysis 79 A 22 B 16




T T Toxicology 96 A 5 B 23 C 15

TBLA TBLA Total Bile Acids 78 A 24 B 20

TBX TBX 11-dehydroThromboxane B2 166 A 7 B 5

TEG TEG Viscoelastometry 164 A 16 B 27

TICP TICP Touch Imprint/Crush Preparation 275 A 25 B 17

TICP1 TICP Touch Imprint/Crush Prep, Additional Participant

275 A 25 B 17

TM TM Tumor Markers 89 A 22 B 23

TMCA TMCA Transfusion Medicine Comprehensive—Competency Assessment

219 A 12 B 11 C 10

TMCAD TMCAD Direct Antiglobulin Test—Competency Assessment

219 A 26 B 15

TMCAE TMCAE Eluate Competency Assessment 220 A 19 B 2

TMCAF TMCAF Fetal Red Cell Quantitation—Competency Assessment

220 A 30 B 5

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


TMO TMO Ticks, Mites and Other Arthropods 189 A 12 B 30

TMU TMU Trace Metals, Urine 103 A 12 B 13

TMWB TMWB Trace Metals, Whole Blood 103 A 26 B 1

TMX TM Tumor Markers, Double Volume 89 A 22 B 23

TNT CAR Troponin T, 2 Challenge 62 A 20 B 29 C 9

TNT5 CAR Troponin T, 5 Challenge 62 A 20 B 29 C 9

TPM TPM CAP/ACMG Thrombophilia Mutations 244 A 19 B 24

TQP TQP Toxicology Quality Program 108 A 11

TRC TRC Transfusion Related Cell Count 218 A 8 B 14 C 27

TTD TTD Tick Transmitted Diseases 200 A 12 B 17

TVAG TVAG T. vaginalis, Molecular 189 A 21 B 19

U U Urine Chemistry—General 68 A 5 B 16

UAA UAA Automated Urine Microscopy 147 A 19 B 30

UAA1 UAA1 Automated Urine Microscopy 147 A 19 B 30

UBJP ELP Urine Bence Jones Protein 76 A 30 B 13

UDC UDC CAP/AACC Forensic Urine Drug Test, Confirmatory

99 A 8 B 30 C 30 D 5

UDS UDS CAP/AACC Urine Drug Testing, Screening 98 A 12 B 18 C 9

UDS6 UDS6 CAP/AACC Urine Drug Testing, Screen, Ltd 98 A 12 B 9

UDSM UDSM Urine Drug Testing, Screen Validated Material

108 A 12 B 18 C 9

UHCG UHCG Urine hCG 150 A 20 B 4 C 17

UMC UMC Urine Albumin and Creatinine, Semiquant 151 A 21 B 24

UPBG UPBG Porphobilinogen, Urine 70 A 30 B 5

URC CRS Urine Crystals 147 A 2 B 3

UT UT Urine Toxicology 96 A 5 B 23 C 15

UTCO UTCO Urine Toxicology Carryover 131 A 14

UVM UVM Urine Chemistry—General, Validated Material

70 A 5 B 16

V V Viscosity 208 A 9 B 9

VBDM VBDM Vector-Borne Disease—Molecular 195 A 29 B 10

VBF VBF Virtual Body Fluid 146 A 2 B 10

VBP VBP Virtual Biopsy Program 258 A 26 B 29 C 27 D 5

VBP1 VBP Virtual Biopsy Program, Additional Pathologist

258 A 26 B 29 C 27 D 5

VF VF Vitreous Fluid, Postmortem 101 A 13 B 14

VGS1 VGS1 Virtual Gram Stain Basic Competency 175 A 23 B 22

VGS2 VGS2 Virtual Gram Stain Advanced Competency 175 A 23 B 22

VIP VIP Variant Interpretation Program 244 A 30

mkite

Text Box

Delayed until 2019

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 21

Prog Code

PFGCode


VIP1 VIP Variant Interpretation Program, Additional Participant

244 A 30

VITD VITD 25-OH Vitamin D, Total 84 A 30 B 26

VLS VLS BK, CMV, and EBV Viral Load 193 A 5 B 25

VLS2 VLS Viral Load 193 A 5 B 25 C 3

VM1 VM Viral Markers—Series 1 224 A 22 B 14 C 27


VM3 VM Viral Markers—Series 3 224 A 22 B 14

VM4 VM Viral Markers—Series 4 224 A 22 B 14



VPBS VPBS Virtual Peripheral Blood Smear 141 A 8 B 30

VR1 VR1 Virology Culture 191 A 29 B 21 C 24

VR2 VR2 Virology Antigen Detection (DFA) 191 A 19 B 16 C 5

VR3 VR3 Infectious Disease Serology 200 A 19 B 5

VR3M VR3 Infectious Disease Serology, Mumps 200 A 19 B 5

VR4 VR4 Virology Antigen Detection (Non-DFA) 192 A 22 B 7 C 13

VRE VRE Vancomycin-Resistant Enterococcus 182 A 23 B 27

VS VS Vaginitis Screen Antigen Detection 181 A 2 B 30 C 29

VS1 VS Vaginitis Screen, T. vaginalis 181 A 2 B 30

VS2 VS2 Vaginitis Screen, Virtual Gram Stain 182 A 12 B 10

WBCR WBCR Whole Blood Creatinine 66 A 26 B 30 C 26

WBGQ WBGQ Quality Cross Check—Whole Blood Glucose 43 A 3 B 10

WID WID Worm Identification 189 A 2 B 5

WP3 WP3 Whole Blood PT/INR, I-STAT 166 A 12 B 7 C 24

WP4 WP4 Whole Blood Citrated PT Hemochron/IL GEM

166 A 12 B 7 C 24

WP6 WP6 Whole Blood Non-Citrated PT Hemochron/IL GEM

166 A 12 B 7 C 24

WP9 WP9 Whole Blood Coagulation—CoaguChek, XS Plus

166 A 29 B 21 C 10

WP10 WP10 Whole Blood Coag—CoaguChek XS System 166 A 21 B 10

Y Y Ligand—Special 84 A 30 B 24

YVM YVM Ligand—Special, Validated Material 90 A 30 B 24

YY Y Ligand—Special, Additional Volume 84 A 30 B 24

Z C TDM—General, Comprehensive 56–58 A 12 B 4 C 1

ZAP70 ZAP70 ZAP-70/CD49D Analysis by Flow Cytometry 212 A 1 B 13

ZE ZE Therapeutic Drug Monitoring—Extended 60 A 13 B 14

ZT ZT Therapeutic Drug Monitoring—Special 60 A 12 B 26

Sur

veys

Pro

gram

Shi

ppin

g

2018 PAP Shipping



PAP Proficiency Testing With Education

DescriptionProgram Code (Institution)

Program Code (Individual) Page Calendar of Shipment Dates

PAP PT

PAPCPT (Conventional) APAPCPT 272

Laboratory will choose one of 20 dates for testing event.

Feb 5 Mar 5 April

2 May 7 June 4 July 9 Aug 6 Sept

10Oct

9 Nov 5

Feb 20

Mar 19

April 16

May 21

June 18

July 23

Aug 20

Sept 24

Oct 22

Nov 26

PAPKPT (SurePath) APAPKPT 272

PAPJPT (Combination) APAPJPT 272

PAPLPT (Liquid Based) APAPLPT 272

PAPMPT (ThinPrep) APAPMPT 272

Education No additional charge

Laboratory must choose from Series 1 or 2

Series 1, A mailing: February 12-March 5 Series 1, B mailing: August 13-September 3

Series 2, A mailing: May 14-June 4 Series 2, B mailing: November 5-November 26

Enrollment for laboratories with CLIA license with enrollees testing at affiliated sites

PPTENR 272 No shipments associated with this program

For additional programs for PAP PT such as: Extra tests, Retests, CAP provided proctors, and Locum Tenens, please call a Customer Contact Representative at 800-323-4040 or 847-832-7000 option 1.

PAP Education

DescriptionProgram Code (Institution)

Program Code (Individual) Page Calendar of Shipment Dates

PAP Education (Series 1 or 2)

PAPCE1 or 2 (Conventional) APAPCE1 or 2 273 Laboratory must choose from Series 1 or 2

PAPKE1 or 2 (SurePath) APAPKE1 or 2 273

Series 1, A mailing: February 12-March 5 Series 1, B mailing: August 13-September 3PAPJE1 or 2

(Combination) APAPJE1 or 2 273

PAPLE1 or 2 (Liquid Based) APAPLE1 or 2 273

Series 2, A mailing: May 14-June 4 Series 2, B mailing: November 5-November 26PAPME1 or 2

(ThinPrep) APAPME1 or 2 273

For international laboratories and other laboratories not subject to US regulations, that perform gynecologic cytopathology, participation in the CAP Cytopathology Glass Slide Education Program will fulfill the checklist requirement for participation in an interlaboratory peer-comparison educational program in gynecologic cytopathology.

Surveys P

rogram S

hipping

Quality Management Tools Overview


800-323-4040 | 847-832-7000 Option 1 | cap.org 23

2018 Q-PROBESModules/Packages Program Codes

Individual QP Studies QP181, QP182, QP183, QP184

All Four QP Studies PRO

2018 Q-TRACKSModules/Packages Program Codes

Individual Clinical Pathology (CP) MonitorsQT1, QT2, QT3, QT4, QT7, QT8,

QT10, QT15, QT16, QT17

Individual Anatomic Pathology (AP) Monitor QT5

Combined CP/AP Module – Includes all 12 QT Monitors QTP

Clinical Pathology Module – Includes all 10 CP Monitors QTC

2018 Q-MONITORSModule Program Codes

Individual QM Study QM1

Refer to the Quality Management Tools section of the Surveys catalog for program information.

Competency Assessment and Safety & Compliance Program

Your laboratory’s license for Competency Assessment Program is based on the number of individuals who will be using Competency Assessment Program—that is, the number of people for whom you will be assessing competency, not the number of employees in your laboratory. The Safety & Compliance course package is an addition to your Competency Assessment Program order. The same employees enrolled in Competency Assessment Program will have access to Safety & Compliance courses if the additional fee is paid. Refer to pages 15–17 of the Surveys catalog for program information.

Number of Users

Competency Assessment Program Safety & Compliance Courses**

Program Code Program Code

Up to 50 CA0050 XCA0050

51 to 250* CA0250 XCA0250

*More than 250 users: Call 800-323-4040 or 847-832-7000 option 1

**Safety & Compliance course package must be purchased in conjunction with Competency Assessment Program subscription. Not available for purchase separately.

New Cap Filler #5

Go ahead. Double check.

Use the benchtop reference guides to easily and quickly identify cells, fungi, bugs, parasites, bacteria, microorganisms, and other entities. Ruggedly constructed, these handy, fully illustrated guides are built to withstand heavy use at the workbench.

Choose the corresponding code on your Surveys order form:

ABRG Arthropod Benchtop Reference Guide

BFBRG Body Fluids Benchtop Reference Guide

GSBRG Gram Stain Benchtop Reference Guide

HBRG Hematology Benchtop Reference Guide

MBRG Mycology Benchtop Reference Guide

PBRG Parasitology Benchtop Reference Guide

UABRG Urinalysis Benchtop Reference Guide

Or view sample pages and order online:• printed books at estore.cap.org• ebooks at ebooks.cap.org

25554_AllBRG_Filler3.indd 1 6/1/17 10:43 AM2018 CAP NEW Fillers.indd 5 8/10/17 12:10 PM

International Material Handling Information

International Material H

andling Information

Simplify analysis and reporting of PT and accreditation performance using the Performance Analytics Dashboard.• Quickly identify trends/patterns to mitigate risk with

the ability to access up to three years of data.

• Benchmark your laboratory against your peers and CAP wide performance.

• Consolidate multiple CAP numbers to view a single dashboard for an entire system.

Inte

rnat

iona

l Mat

eria

l Han

dlin

g In

form

atio

nInternational Material Handling Information


Customer Contact Center Hours: Monday–Friday, 7:00 am–5:30 pm CT Extended Support Hours: Monday–Friday, 9:00 pm–5:00 am CT (email correspondence only)

CAP Contact InformationContact us to:

• Update contact and/or demographic information (laboratory name, address, contact email address, telephone and fax numbers)

• Receive additional supporting information or documents for ordering or importing purposes

• Ask a CAP expert questions about a specific CAP program

Phone:001-847-832-7000 option 1

Email:Go to cap.org and select CONTACT & SUPPORT at the top of the home page.ORSend an email to [email protected]

Laboratory Accident HotlineAccidental exposures while processing specimens from the CAP, including cuts and contamination of mucous membranes or non-intact skin, should be reported to the CAP hotline for evaluation and questions regarding prophylaxis. Please provide the identification number of the relevant specimen.

001-847-832-7000 option 1 – During Contact Center hours

001-847-470-2812 – All other hours

In countries where the CAP has a designated distributor, directly contact your CAP distributor if you have questions related to pricing or any other inquiry not listed above.

e-LAB Solutions SuiteUse the CAP’s online portal to manage your laboratory improvement programs. The portal provides helpful, convenient, and easy-to-use tools to:

• Access the CAP’s Web-based reporting solution, Performance Analytics Dashboard.

• Enter, review, and approve your PT results with interactive online forms.

• View and print copies of evaluations, participant summary reports, kit instructions, and result forms.

• Access your analyte scorecard, customized PT shipping calendar, and other analytical tools.

• Manage your laboratory’s online access, user permissions, and your individual profile.

• Manage your laboratory’s accreditation documents, including customized accreditation checklists and test menu/activity change forms.

• Enhance your automated reporting capabilities with e-LAB Solutions Connect (available in the US and Canada).

• Connect to CAP Learning tools, assessments, and modules.

This site contains a Users Guide that will guide you through the process of using e-LAB Solutions Suite. When you opt in to e-LAB Solutions Suite, your laboratory will receive important email notifications regarding PT events such as kit and evaluation availability.

Program CertificatesAt the completion of the CAP program year, participating laboratories will receive a program certificate that recognizes each institution’s participation in the CAP Surveys and Anatomic Pathology Education Programs. These certificates are an indication of your commitment to quality improvement for better patient care.


andling Information


800-323-4040 | 847-832-7000 Option 1 | cap.org 27

Program Usage and Materials • All program materials are intended for PT use only.

• You may not transfer or incorporate PT samples, their progeny, unmodified derivatives, or modifications thereof into a program intended for sale or uses other than PT, quality assurance, or education.

• When you dispose of PT samples, their progeny, unmodified derivatives, or modifications thereof, reagents, and disposable equipment used in PT, you should autoclave or incinerate and dispose of these items as hazardous waste.

• All directions concerning use of the program materials are intended as guidance only.

• No license is either granted or implied by the sale of any program.

• It is the CAP’s policy to only use donor-based specimens when informed consent has been obtained in conjunction with internal review board approval by the collection facility.

• The CAP contracts with several vendors in producing the materials for its PT programs.

• The CAP follows PT manufacturer directions for determination of transport packing and shipping conditions. These requirements may differ from the in-laboratory storage specifications indicated in the kit instructions that accompany your PT. Upon delivery of your PT, follow the kit instructions immediately and conduct the CAP PT testing as soon as possible.

Biohazard Information/Warning Statements • The Centers for Disease Control and Prevention (CDC) has classified all bacterial and viral strains used in PT challenges

as not greater than a Biosafety Level 2. You can find a full description of Biosafety Level 2 handling requirements, as defined by the CDC Office of Health and Safety in Biosafety in Microbiological and Biomedical Laboratories, at cdc.gov/biosafety/publications/bmbl5/index.htm.

• All Surveys include a biohazard warning statement appropriate for handling of the material.

• Surveys that do not include etiologic agents are still expected to be handled in keeping with CDC universal precautions and Occupational Safety and Health Administration (OSHA) bloodborne pathogen rules.

• The CAP’s Safety Data Sheets (SDS) are available on cap.org (Catalog and Ordering Information page).

PT ReferralLaboratories must not communicate results, share PT specimens, or refer PT specimens to another laboratory for tests not on the laboratory’s menu even if the referral for testing is routinely performed for patient specimens.

Additional Information for International Participants to Ensure Timely Delivery of PT Programs

Permits and Clearance DocumentationSome countries may require additional import permits or certificates of origin for customs clearance (regardless of dangerous goods status of a program).

• Work with your in-country distributor and local authorities to determine if any permits are required.

• As a recipient, you are responsible for obtaining any import permits/documents and forwarding these to the CAP or your local distributor for inclusion with the program shipment for customs clearance at the port of entry. Provide all necessary documents to your broker, carrier, and/or customs authorities in a timely manner. The CAP will not be responsible for providing replacement shipments due to lengthy clearance delays due to lack of paperwork.

• Do not use the CAP Surveys catalog program descriptions for permit preparation and customs clearance documents. Program specifications may have changed after catalog publication and do not provide sufficient detail. Ask your in-country distributor or contact the CAP to obtain such information.

• Programs with dangerous goods materials may require special permits and incur additional shipping and handling charges.

• You are responsible for monitoring permit expiration dates and submitting a new permit a minimum of six weeks prior to the scheduled ship date, and preferably at the time of ordering. Check with your in-country distributor which may have longer lead time requirements.

• Permits should contain an extended expiration date preferably of December 31, 2018 in order to cover all shipments.

• Program materials will not ship without required documentation.

Inte

rnat

iona

l Mat

eria

l Han

dlin

g In

form

atio



Additional DocumentationContact the CAP if you require additional documentation to place orders or receive shipments. Examples of available documentation include: US IRS Form 6166 Certificate of Residency, Articles of Incorporation, and the CAP’s tax status.

Programs that may require import permits are listed below and are accurate as of May 1, 2017.

Permit Requirements and Dangerous Goods Classification

Program Code Program Name Dangerous Goods Classification

ABL Accuracy-Based Lipids UN3373

ABS Accuracy-Based Testosterone, Estradiol UN3373

ABU Accuracy-Based Urine UN3373

ABVD Accuracy-Based Vitamin D UN3373

BCS Blood Culture UN3373

BCS1 Blood Culture, Staphylococcus aureus UN3373

BDP, BDP5 Bacterial Detection in Platelets UN3373

BDPV, BDPV5 Bacterial Detection in Platelets, Rapid UN3373

BSTS Bacterial Strain Typing, Staphylococcus UN3373

CAMP Campylobacter UN3373

CRYP Cryptococcal Antigen Detection UN3373

D Bacteriology UN3373

DEX Expanded Bacteriology UN3373

D1 Throat Culture UN3373

D2 Urine Culture UN3373

D3 N. gonorrhoeae Culture UN3373

D4 Bacteriology—Limited UN3373

D7 Throat/Urine Culture UN3373

D8 Group B Strep Detection UN3373

E Mycobacteriology UN3373

E1 Mycobacteriology—Limited UN3373

F Mycology UN3373

F1 Yeast UN3373

F3 Candida Culture UN3373

HC4 Herpes Simplex Virus, Culture UN3373

HC6, HC6X C. trachomatis and N. gonorrhoeae by NAA UN3373

HPS Helicobacter pylori Antigen, Stool UN3373

IDN Nucleic Acid Amplification, Organisms without MTB UN3373

IDO Nucleic Acid Amplification, Organisms UN3373

LN24 Creatinine Accuracy Calibration Verification/Linearity UN3373

LN38 CMV Viral Load Calibration/Linearity UN3373

MBT Microbiology Bench Tools Competency UN3373

MC1 Microbiology—Combination w/GC UN3373

Continued on the next page


andling Information


800-323-4040 | 847-832-7000 Option 1 | cap.org 29

Permit Requirements and Dangerous Goods Classification continued

Program Code Program Name Dangerous Goods Classification

MC2 Microbiology—Combination UN3373

MC3 Urine Colony Count UN3373

MC4 Urine Colony Count Combination UN3373

MC5 Throat & Urine Culture/Rapid Strep A Antigen Detection UN3373

MRS Methicillin Resistant S. aureus, 2 Challenge UN3373

MRS5 Methicillin-Resistant Staphylococcus aureus, 5 Challenge UN3373

PNA1 PNA FISH for Staphylococcus UN3373

PNA2 PNA FISH for Yeast UN3373

VM1* CAP Viral Markers—Series 1 *






VR1 Virology Culture UN3373

VRE Vancomycin-Resistant Enterococcus UN3373

VS Vaginitis Screen Antigen Detection UN3373

WARNING: The Instrumentation (I) Survey specimens may contain corrosive or toxic substances, environmental hazards, or irritants. This Survey ships as a Class 9 dangerous good with a specimen volume below the threshold requiring special packaging.

*This program does not ship under a Dangerous Goods Classification; however, some countries may still require permits due to the nature of the material.

Note: A refund cannot be issued for any paid fees once the shipment has been released, six weeks prior to the first scheduled ship date of the year. Participants are responsible for all costs and expenses related to the return of shipments to the CAP or its designated distributor if the reason for such return is late program cancellation, refused shipment, customs clearance issues, or invalid ship-to address.

Inte

rnat

iona

l Mat

eria

l Han

dlin

g In

form

atio



StabilitySome programs have limited stability and may not be available in certain countries. For more information, contact the CAP or your in-country distributor’s customer service department.

Programs With 10 or Less Days StabilityProgram Code Program Name

B27* HLA-B27 Typing

CBT* Cord Blood Testing

EPO Erythropoietin

FL3* Flow Immunophenotypic Characterization of Leukemia/Lymphoma

GH2, GH5 Hemoglobin A1c

GHQ Quality Cross Check—Hemoglobin A1c

HCV2 Hepatitis Viral Load (HCV) Load

HFC* Hemocytometer Fluid Count

JAT Transfusion Medicine Automated

LN15 Hemoglobin A1c Accuracy Calibration Verification/Linearity

MX1B HLA Crossmatching, Antibody Screen and Identification (Class I)

MX1C HLA Crossmatching, Antibody Screen and Identification (Class I)

MX2B HLA Crossmatching, Antibody Screen and Identification (Class II)

MX2C HLA Crossmatching, Antibody Screen and Identification (Class II)

MXB MX1B/MX2B Combination, Class I & II

MXC MX1C/MX2C Combination, Class I & II

NIPT Noninvasive Prenatal Testing

RAG Red Blood Cell Antigen Genotyping

RFAV1* Rare Flow Antigen Validation, CD1A

SCP* Stem Cell Processing

ZAP70* ZAP-70/CD49D Analysis by Flow Cytometry

Note: The CAP strives to deliver all program materials in a stable condition. Surveys that must be kept cold will ship with frozen cold packs or dry ice as needed and allowed by country importation regulations. If transportation to your location cannot meet these conditions, please note that replacements will not be available.

For CAP-accredited international laboratories, the CAP requests that your laboratory perform testing on these materials. If unacceptable results are achieved and it is established such results are due to shipping conditions, your laboratory may review options with the CAP Laboratory Accreditation Program staff at [email protected].

*Programs with less than five days stability may not be suitable for participants located outside the US and Canada.


andling Information


800-323-4040 | 847-832-7000 Option 1 | cap.org 31

Dry IceSome shipments are packed on dry ice to maintain stability. Dry ice shipments are shipped as UN1845 dangerous goods shipments. Due to sublimation, there may not be any dry ice present when you open your kit. This condition is not an indication that the program material has been compromised. If your country does not allow dry ice shipments, your Surveys will be packaged with cool packs that may not be as effective in maintaining a cool environment. When you receive your shipment, follow the kit storage instructions as soon as possible.

Program Materials Shipped on Dry IceProgram Code Program Name

ABL Accuracy-Based Lipids

ABS Accuracy-Based Testosterone, Estradiol

ABTH Harmonized Thyroid

ABU Accuracy-Based Urine

ABVD Accuracy-Based Vitamin D

ACA Antichromatin Antibody

AG* 1,5-Anhydroglucitol

ARP Antiribosomal P Antibody

BDPV, BDPV5 Bacterial Detection in Platelets, Rapid

BGL, BGL1 CAP/ACMG Biochemical Genetics

BNP, BNP5 B-type Natriuretic Peptides

C1*, C3*/C3X*,C4*,CZ*/CZX*, CZ2X*/CZVM*, Z* Chemistry and Therapeutic Drug Monitoring

CFDNA Cell Free DNA

CGS6, CGS8 Heparin-Induced Thrombocytopenia

CRT, CRTI Cardiac Markers

CS* CAP/AACC Immunosuppressive Drugs

CZQ Quality Cross Check—Chemistry/Therapeutic Drug Monitoring

DAI* Urine Drug Adulterant/Integrity Testing

DFC Drug-Facilitated Crime

DMPM* Drug Monitoring for Pain Management

EPO* Erythropoietin

ETB* Ethanol Biomarkers

EV* Everolimus

FOL* RBC Folate

FT* Fructosamine

GSA* Glycated Serum Albumin

HCV2 Hepatitis C Viral Load

HV2 HIV Viral Load

HIVG HIV Genotyping

IGHV IGHV Mutation Analysis

K*, KK*, K2*, KVM* Ligand Assay—General

LN2, LN2BV Chemistry Calibration Verification/Linearity

Continued on the next page

*This program ships with a cool pack to laboratories in the US, Puerto Rico, Guam, Virgin Islands, American Samoa, and to APO/FPO addresses.

Inte

rnat

iona

l Mat

eria

l Han

dlin

g In

form

atio



Program Materials Shipped on Dry Ice continued

Program Code Program Name

LN5*, LN5S* Ligand Calibration Verification/Linearity

LN24 Creatinine Accuracy Calibration Verification/Linearity

LN25, LN27 Troponin Calibration Verification/Linearity

LN30 B-type Natriuretic Peptides Calibration Verification/Linearity

LN31 Immunosuppressive Drugs Calibration Verification/Linearity

LN35, LN36, LN37 Coagulation Calibration Verification/Linearity

LN38 CMV Viral Load Calibration Verification/Linearity

LN41 Procalcitonin Calibration Verification/Linearity

LN44 Fibrinogen Calibration Verification/Linearity

LN45 Hepatitis C Viral Load

LPE* Electrophoresis

MHO, MHO1, MHO2, MHO3, MHO5 Molecular Hematologic Oncology

MPA* Mycophenolic Acid

MRD, MRD1, MRD2 Minimal Residual Disease

NB*, NB2* Neonatal Bilirubin

NGSHM Next-Generation Sequencing, Hematologic Malignancies

NGSST Next-Generation Sequencing, Solid Tumor

NTA Nicotine and Tobacco Alkaloids

OFD* Oral Fluid for Drugs of Abuse

RNA RNA Sequencing

SALC Salivary Cortisol

SARC Sarcoma Translocation

SCDD* Synthetic Cannabinoids/Designer Drugs

SCO* Serum Carryover

T* Toxicology

TBLA Total Bile Acid

TM, TMX Tumor Markers

TNT, TNT5 Troponin T

TQP* Toxicology Quality Program

UDS*, UDSM*, UDS6* CAP/AACC Urine Drug Testing, Screening

UDS6 CAP/AACC Urine Drug Testing, Screen, Ltd

UPBG Porphobilinogen Urine

UT Urine Toxicology

UT*, UTCO* Urine Toxicology Carryover

VF* Vitreous Fluid Analysis

VITD* 25-OH Vitamin D

Y*, YY*, YVM* Ligand—Special

ZE* Therapeutic Drug Monitoring—Extended

*This program ships with a cool pack to laboratories in the US, Puerto Rico, Guam, Virgin Islands, American Samoa, and to APO/FPO addresses.

mkite

Text Box

Delayed until 2019

Insight at a glance.

In just seconds, the CAP’s Performance Analytics Dashboard provides valuable insights into your laboratory’s performance, letting you proactively focus energy on areas that need immediate attention while filtering out distractions. Updated daily, this complimentary Surveys and CAP accreditation performance monitoring tool reduces the stress of managing today’s laboratory by giving you fast access to a single laboratory’s or an expansive network’s performance.

To view a demo, search Performance Analytics Dashboard at cap.org.

Simplify your calibration verification/linearity efforts.

Calibration and analytical measurement range (AMR) verification procedures are an important element of a laboratory’s quality management plan to verify the continued accuracy of testing systems; and they are requirements of the CAP’s Laboratory Accreditation Program.

Our Calibration Verification/Linearity (CVL) program is a comprehensive solution designed to simplify these procedures and satisfy regulatory requirements.

• Mimic patient testing and ensure confidence in your linearity results with human-based specimens across five to eight levels.

• Receive a customized and easy-to-interpret report package based on rigorous statistical analysis.

• Confidently verify calibration by participating in programs with the largest peer group comparisons.

For program details and ordering information, see the Instrumentation Validation Tools section of the 2018 Surveys catalog, or visit cap.org and click on the SHOP tab.

Expedite results—receive linearity evaluations for most CVL programs within two business days through our LN ExpressSM service.

Get the most comprehensive offering of innovative and scientifically developed proficiency testing programs. From routine to esoteric, our programs help you deliver performance you can measure and accuracy you can trust.

• Accuracy-Based Programs

• Anatomic Pathology

• Blood Gas, Critical Care, and Oximetry

• Coagulation

• Continuing Education

• Endocrinology

• Forensic Sciences

• General Chemistry and Therapeutic Drug Monitoring

• Genetics and Molecular Pathology

• Hematology and Clinical Microscopy

• Histocompatibility

• Immunology and Flow Cytometry

• Instrumentation Validation Tools

• Microbiology

• Point-of-Care

• Quality Cross Check

• Quality Management Tools

• Reproductive Medicine

• Toxicology

• Transfusion Medicine, Viral Markers, and Parentage Testing

© 2017 College of American Pathologists. All rights reserved. 25472.0717

cap.org

325 Waukegan Road

Northfield, IL 60093-2750

800-323-4040

847-832-7000 (Country code: 001)

2018 Shipping and Ordering Supplement - cgikk.com · Insight at a glance. In just seconds, the...

Documents

Transcript of 2018 Shipping and Ordering Supplement - cgikk.com · Insight at a glance. In just seconds, the...